Skip to main content
. 2023 Oct 10;13:18. doi: 10.1038/s41387-023-00247-1

Table 1.

Baseline characteristics of participants according to their MIND diet score.

MIND diet score
Characteristics Total (N = 6887) Low (N = 3846) High (N = 3041) P-value
Age (years) 47.13 ± 0.45 45.04 ± 0.43 49.66 ± 0.61 < 0.0001
Sex, n (%) < 0.0001
Male 3181(46.19) 1927(50.80) 1254(39.13)
Female 3706(53.81) 1919(49.20) 1787(60.87)
Race/ethnicity, n (%) < 0.001
Non-Hispanic White 3809(55.31) 2073(70.52) 1736(75.53)
Non-Hispanic Black 1333(19.36) 847(13.64) 486(8.67)
Mexican American 1272(18.47) 671(7.74) 601(8.20)
Others 473(6.87) 255(8.10) 218(7.60)
Education level, n (%) < 0.0001
Less than high school 1831(26.59) 1143(19.48) 688(12.50)
High school or equivalent 1730(25.12) 1079(30.83) 651(21.49)
College or above 3326(48.29) 1624(49.68) 1702(66.01)
Family income to poverty ratio, n (%) < 0.0001
< 1 1077(15.64) 679(13.06) 398(8.82)
≥ 1 & < 3 2781(40.38) 1636(37.41) 1145(31.55)
≥ 3 2715(39.42) 1352(45.02) 1363(56.08)
Unknown 314(4.56) 179(4.51) 135(3.55)
Smoking status, n (%) < 0.0001
Never 3526(51.2) 1887(46.69) 1639(53.92)
Former 1920(27.88) 963(22.55) 957(30.43)
Current 1441(20.92) 996(30.76) 445(15.65)
BMI (kg/m2), n (%) 0.07
< 25.0 2082(30.71) 1141(33.70) 941(33.80)
25.0–29.9 2356(34.75) 1274(31.64) 1082(34.85)
≥ 30.0 2341(34.53) 1370(34.66) 971(31.35)
Physical activity, n (%) < 0.0001
Sedentary 1774(25.76) 1114(21.93) 660(15.03)
Insufficient 2621(38.06) 1454(41.57) 1167(41.41)
Moderate 1129(16.39) 591(16.74) 538(19.04)
High 1363(19.79) 687(19.77) 676(24.52)
Diabetes, n (%) 1021(14.83) 581(11.04) 440(10.78) 0.79
Hypertension, n (%) 2984(43.33) 1687(38.06) 1297(38.27) 0.92
Hyperlipidemia, n (%) 4954(71.93) 2775(70.09) 2179(69.96) 0.93
Heart failure 264(3.83) 166(2.87) 98(2.34) 0.37
Ischemic heart disease 498(7.24) 289(5.81) 209(5.10) 0.32
Myocardial infarction 361(5.24) 211(4.25) 150(3.65) 0.63
TC (mg/dL) 200.23 ± 0.70 198.60 ± 0.76 202.20 ± 1.25 0.02
TG (mg/dL) 142.74 ± 2.53 145.97 ± 3.38 138.86 ± 4.20 0.22
LDL-C (mg/dL) 115.77 ± 0.84 115.81 ± 1.25 115.72 ± 1.33 0.96
HbA1C (%) 5.47 ± 0.02 5.47 ± 0.02 5.46 ± 0.02 0.48
Fasting glucose (mg/dL) 5.65 ± 0.04 5.63 ± 0.05 5.68 ± 0.06 0.38
eGFR (mL/min/1.73 m2) 93.13 ± 0.66 94.95 ± 0.60 90.91 ± 0.84 < 0.0001
Waist circumference (cm) 97.53 ± 0.45 98.21 ± 0.47 96.71 ± 0.63 0.03
Energy intake (Kcal) 2117.02 ± 15.62 2159.73 ± 17.75 2065.08 ± 23.42 0.001
DAPT 8(0.12) 4(0.09) 4(0.04) 0.40
Statin therapy 1073(15.59) 576(13.13) 497(13.95) 0.45
Hypoglycemic treatment 630(9.16) 357(6.62) 273(6.58) 0.94

Data are presented as weighted means ± SEs for continuous variables and unweighted numbers (weighted percentages) for categorical variables.

MIND diet Mediterranean-DASH Diet Intervention for Neurodegenerative Delay diet, BMI Body mass index, TC Total cholesterol, TG Triglyceride, LDL-C Low-density lipoprotein cholesterol, HDL-C High-density lipoprotein cholesterol, HbA1c Glycosylated hemoglobin, type A1C; eGFR estimated glomerular filtration rate, DAPT Dual antiplatelet therapy.